$BNTX

BioNTech CEO Ugur Sahin Sold $3.86 Million in BNTX Shares

The chief executive sold 39,000 shares on September 24, 2026, the sixth open-market sale he filed during the month, bringing September sales to about $17.8 million.

SH

By Sam Hall

Founder & Editor

Ugur Sahin, chief executive officer of BioNTech SE ($BNTX), sold 39,000 shares on September 24, 2026. The open-market transaction was valued at $3,860,660.70, with shares sold at $98.99 each. The Form 4 covering the sale was filed the same day. Sahin reported holding 341,209 shares after the sale. BioNTech, a biotechnology company, had a market capitalization of about $25.3 billion.

BioNTech shares closed at $98.46 on September 23, the session before the sale. They traded between $98.31 and $101.31 that day. The stock had closed at $96.69 on September 15, $95.83 on September 16, $98.66 on September 17, $96.06 on September 18, $98.00 on September 21, and $100.87 on September 22. The September 24 sale price of $98.99 per share was above the September 23 close of $98.46.

The disposal was the sixth open-market sale by Sahin during September 2026. The six transactions totaled 182,000 shares and $17,803,788.60. The earlier September sales included 34,000 shares on September 15 at $96.49, 15,000 shares on September 16 at $96.09, 34,000 shares on September 17 at $98.60, 30,000 shares on September 18 at $96.22, and 30,000 shares on September 23 at $99.40. The September 15 and 16 sales were filed on September 16; the September 17 and 18 sales were filed on September 18; and the September 23 and 24 sales were filed together on September 24.

Sahin was not the only BioNTech executive to file a Form 4 sale in 2026. Chief operating officer Sierk Poetting sold 50,000 shares on April 22 at $110.56 per share, a transaction totaling $5,527,960. The April 23 filing left 399,387 shares reported after the sale. That sale was also reported as an open-market transaction.

Congressional STOCK Act disclosures on file for $BNTX showed no 2026 activity. The most recent entry was a sale by Representative Valerie Hoyle, a Democrat, recorded with an August 7, 2025 trade date and disclosed on September 12, 2025. Representative Josh Gottheimer, a Democrat, filed several earlier $BNTX transactions: purchases on December 5, 6, and 7, 2023; a sale on March 14, 2024; a purchase on April 15, 2024; and sales on August 30 and September 3, 2024. Representative Ro Khanna, a Democrat, also filed a sale recorded with a January 20, 2022 trade date. Congressional dollar figures are midpoint estimates of disclosed bracketed ranges.

After the September 24 sale, Sahin's reported position stood at 341,209 shares. Per-share prices across the September series ranged from $96.09 to $99.40, and each of the six sales was listed in SEC filings as an open-market transaction. The filing-lag pattern across the series ranged from zero to one day, with the final two sales reported together on the trade date.


This post was generated by InsiderTradingTracker.co's automated newsroom and fact-checked against the underlying SEC and Congressional disclosure data. Numerical claims trace to primary sources. Not investment advice.

Related posts